Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization | Zendy

Ramin Nourinia | Zendy; Mozhgan Rezaei Kanavi | Zendy; Amir Kaharkaboudi | Zendy; Seyed Iman Taghavi | Zendy; Seyed Javid Aldavood | Zendy; Soesiawati R. Darjatmoko | Zendy; Shoujian Wang | Zendy; Zafer Gürel | Zendy; Jeremy A. Lavine | Zendy; Sare Safi | Zendy; Hamid Ahmadieh | Zendy; Narsis Daftarian | Zendy; Nader Sheibani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization

Author(s) -

Ramin Nourinia,

Mozhgan Rezaei Kanavi,

Amir Kaharkaboudi,

Seyed Iman Taghavi,

Seyed Javid Aldavood,

Soesiawati R. Darjatmoko,

Shoujian Wang,

Zafer Gürel,

Jeremy A. Lavine,

Sare Safi,

Hamid Ahmadieh,

Narsis Daftarian,

Nader Sheibani

Publication year - 2015

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.15-17169

Subject(s) - choroidal neovascularization , medicine , propranolol , ophthalmology , electroretinography , neovascularization , saline , pedf , choroid , retina , anesthesia , retinal , angiogenesis , biology , neuroscience

Determine the safe dose of intravitreal propranolol (IVP), and evaluate its inhibitory effect on laser-induced choroidal neovascularization (CNV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore